| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.6B | $0.5B | $0.5B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B |
| EPS (Basic) | $4.04 | $3.88 | $3.64 | $3.86 | $4.32 | $2.91 | $3.59 | $3.79 |
| EPS (Diluted) | $4.04 | $3.87 | $3.64 | $3.85 | $4.31 | $2.91 | $3.58 | $3.78 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $32.9B | $32.0B | $31.7B | $31.9B | $36.7B | $32.9B | $26.1B | $25.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $29.1B | $28.7B | $28.7B | $29.4B | $33.2B | $29.5B | $22.9B | $22.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.8B | $3.3B | $2.9B | $2.5B | $3.4B | $3.4B | $3.1B | $2.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.5B | $0.6B | $0.6B | $0.6B | $0.5B | $0.6B |
| Investing Cash Flow | $-0.5B | $0.5B | $2.2B | $0.2B | $-2.1B | $-5.4B | $-0.7B | $-0.1B |
| Capital Expenditures | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $-0.4B | $-0.9B | $-4.2B | $3.6B | $6.1B | $-0.1B | $0.2B |